ABSTRACT
INTRODUCTION
Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality worldwide 1 , and its effects do not end with delivery: it is associated with a lifelong increased cardiovascular (CV) risk 2 . This increased risk can be explained in part by left ventricular (LV) systodiastolic impairment 3, 4 , arterial stiffening [5] [6] [7] and endothelial dysfunction 7 , which have been documented both during and after PE. These phenomena, which influence each other, are related to myocardial and vascular remodeling, a process not yet fully understood which leads to loss of function and fibrous tissue deposition.
The best way to quantify the extent of myocardial fibrosis is histological examination on endomyocardial biopsy, which is an invasive technique. Contrast-enhanced cardiac magnetic resonance imaging (CMR) is considered the non-invasive gold standard to detect LV fibrosis 8 , and has been validated against histology, but its use is limited by low availability and high cost. By means of ultrasonic integrated backscatter (IBS), two-dimensional (2D) echocardiographic imaging is also able to study LV fibrosis, and has been similarly validated against histological examination on endomyocardial biopsy 9, 10 . Compared with CMR, it is more widely available and easier to use, providing information on myocardial reflectivity to the ultrasound beam 9, 10 . Previous studies have applied IBS successfully in several kinds of patient, including those who were hypertensive, obese or affected by coronary artery disease, in order to evaluate fibrosis in the LV [11] [12] [13] , whereas, to the best of our knowledge, IBS has not yet been applied to the ascending aorta.
The aim of this study was to assess, by means of 2D echocardiography, LV and aortic fibrosis in women with a history of early-onset (EO) or late-onset (LO) PE. We also aimed to investigate the relationship between myocardial and aortic fibrosis and other parameters, including postpartum 2D echocardiography indices, gestational age (GA) at onset of PE and uterine artery (UtA) Doppler velocimetry.
SUBJECTS AND METHODS

Subjects
This was a cross-sectional single-center case-control study, in compliance with the 1975 Declaration of Helsinki, approved by the local ethics committee and conducted according to STROBE guidelines 14 . We searched retrospectively our electronic database for all women with a diagnosis of PE at the Maternal Fetal Medicine Unit of the Department of Obstetrics and Gynecology, University of Brescia, Italy between January 2009 and December 2013. PE was defined, according to the International Society for the Study of Hypertension in Pregnancy, as blood pressure (BP) of at least 140/90 mmHg, on two occasions 4-6 hours apart, after the 20 th week of gestation, in previously normotensive women, accompanied by proteinuria ≥ 300 mg/24 h 15 . EO-PE was defined as PE requiring delivery before 34 weeks of gestation.
All women were recalled by phone between 6 months and 4 years after delivery to assess their eligibility. We excluded women with any of the following CV risk factors: smoking habit, dyslipidemia, overweight/obesity, diabetes mellitus and chronic hypertension. We also excluded those with multiple pregnancy, chromosomal abnormality or fetal malformation, maternal cardiopathy, nephropathy or immune disorder, or PE superimposed on chronic hypertension. In addition, we considered only women showing normal BP values and absence of any pathological proteinuria 6 months after delivery. Considering the sample-size calculation, cost effectiveness and available resources, only 60 subjects (30 EO-PE and 30 LO-PE) were selected arbitrarily and requested to attend for postpartum follow-up. Thirty healthy women, matching the exclusion criteria, who delivered in our hospital on the same days as the enrolled cases were considered as controls.
Demographic and clinical data during pregnancy were collected from obstetric charts of all included subjects. A baby was considered small-for-gestational age if birth weight was <10 th percentile for GA on the basis of national growth charts 16 . Intrauterine growth restriction (IUGR) was defined as fetal abdominal circumference < 10 th percentile according to local standards 17 , with umbilical artery pulsatility index (PI) > 95 th percentile. All prenatal ultrasound scans had been performed by experienced sonographers, using an iU22 ultrasound system equipped with a V6-2 curved-array volume transducer (Philips Healthcare, Bothell, WA, USA). UtA Doppler measurements were obtained at the apparent crossover of the uterine and external iliac arteries. PIs of both UtAs were measured and their mean calculated.
After providing written informed consent to participate, all women underwent peripheral blood BP measurement and echocardiography at our Cardiology Unit, in a single, temperature-controlled room.
Blood-pressure measurement
BP was assessed using a standard, calibrated, electronic sphygmomanometer (OMRON Healthcare, Hoofddorp, The Netherlands), with the woman in a resting state and sitting at a 45
• angle. Systolic BP (SBP) was considered to be high if it was > 140 mmHg, while diastolic BP (DBP) was considered high when it was > 90 mmHg. DBP was first measured in both arms, and the one with the highest sitting DBP was used for a further two measurements and the mean of these three measurements was recorded. When possible, the same staff member obtained BP measurements in a particular patient, at the same time of day, using the same equipment. Mean arterial pressure (MAP) was calculated as: (SBP + 2 × DBP)/3.
Echocardiography with integrated backscatter (IBS) analysis
Echocardiographic examinations were performed using a Vivid 7 machine (GE Healthcare Ultrasound, Milwaukee, WI, USA), equipped with a 3.5-MHz transducer. Digital loops were stored on the hard disk of the machine and transferred to an EchoPac Vingmed workstation (GE Healthcare Ultrasound) for offline analysis. Participants were placed in the left lateral decubitus position and images acquired from the standard parasternal long-axis view. Grayscale loops of three consecutive cardiac cycles were acquired at rates of 80-120 frames/s. Calibrated IBS (cIBS) is a marker of myocardial reflectivity to ultrasound and is measured in decibels, conventionally as negative numbers. In the heart, the pericardium has the highest reflectivity due to its fibrous content, while the blood has the lowest; the myocardium shows intermediate reflectivity, which increases (becoming less negative) as the extent of fibrosis increases. A 9 × 9-mm region of interest (ROI) was placed on the basal interventricular septum (IVS) and on the basal posterior wall (PW), a 5 × 5-mm ROI was placed on the anterior wall of the ascending aorta, 3 cm above the valve, while a 2 × 3-mm ROI was placed on the pericardium; their position was adjusted to obtain the same region in each frame. Myocardial reflectivity was measured at a fixed point in each of the three consecutive cardiac cycles (i.e. at the peak of the QRS complex on the electrocardiogram) and averaged. cIBS of the IVS (cIBS IVS ), the PW (cIBS PW ) and the ascending aorta (cIBS AO ) were obtained by subtracting the average pericardial IBS intensity from the average IBS intensity at the IVS, PW and ascending aorta, respectively ( Figure 1 ) 9,11-13 . In order to limit intra-and interobserver variability, all examinations were performed by a single expert echocardiographer (E.V.) who was blinded to the prior medical history. LV 2D strain and aortic echocardiography in the same population have been described elsewhere 4, 6 .
Statistical analysis
Continuous variables were tested visually for normality using Q-Q plots and were expressed as mean and SD; categorical variables were expressed as frequency (n) 6 . Finally, multivariate regression analysis using the 'enter' method was performed to assess the association between cIBS IVS , cIBS PW and cIBS AO from 6 months to 4 years after delivery (as the dependent variables) and pregnancy data from both PE groups as the independent variables (GA, SBP, DBP, UtA-PI at diagnosis of PE and birth-weight percentile). No a-priori sample size calculation was possible due to the lack of data for the parameters investigated in this clinical setting. The post-hoc sample size calculation showed that the size was adequate with 85% power and a 0.05 Type-I risk for all parameters. Statistical analysis was performed using IBM SPSS Statistics for Windows, version 20 (IBM Corp., Armonk, NY, USA). All values were two-tailed and statistical significance was set at P < 0.05.
RESULTS
We identified in our electronic database 388 women with most recent previous pregnancy complicated by PE during the period considered (January 2009 to December 2013); of these women, 41 who had been affected by EO-PE and 57 who had had LO-PE were eligible for the study, and 30 from each group were chosen arbitrarily and included ( Figure S1 ). All women were free from medication, including oral contraceptives, at the time of assessment. Data related to the index pregnancy have been reported previously 4 and are presented in Table S1 . Age and parity did not differ among the three groups. Various parameters were worse in EO-PE compared with LO-PE cases: SBP was lower and DBP was higher, mean UtA-PI at diagnosis of PE was higher, GA at delivery was lower, birth weight was lower and the rates of IUGR and Cesarean section were higher in the EO-PE cases. Data for baseline patient characteristics at cardiological assessment have been reported previously 4 and are presented in Table  S2 . While BP measurements were within the normal range, DBP and MAP were significantly higher in the EO-PE group than in both the LO-PE group and controls, and SBP was higher in the EO-PE than in the LO-PE group.
Standard echocardiographic parameters are given in Table S3 . In the EO-PE group, LV 2D strain and elastance were more impaired than in the other two groups, and aortas had reduced elasticity. Aortas in both EO-PE and LO-PE groups were also generally larger than those of controls, although the diameter at the aortic arch was smaller in the LO-PE group compared with controls. cIBS imaging showed that, in the EO-PE group, the LV was more fibrotic compared with in LO-PE cases and controls, whereas the aorta was no different (Table 1 ). However, due to unsatisfactory image quality, cIBS AO was available for only 13 EO-PE cases, six LO-PE cases and 19 controls, while the other cIBS findings were available for all patients studied. Stepwise multivariate regression analysis showed that cIBS IVS and cIBS PW were associated independently with lower GA, higher SBP, DBP and mean UtA-PI at diagnosis of PE, and lower birth weight (Table 2) . Of LV properties investigated previously in the same population 4 , cIBS IVS correlated with circumferential 2D strain (ρ = -0.510, P = 0.003) and ventricular-arterial coupling (VAC) (ρ = -0.544, P = 0.001), while cIBS PW did not correlate with any tested variable. cIBS IVS and cIBS PW also correlated with each other (ρ = 0.503, P = 0.002). Among the ascending aorta and peripheral vasculature parameters investigated previously in the same population 4, 6, 7 , cIBS AO correlated with carotid-femoral pulse wave velocity (cfPWV) (ρ = 0.901, P = 0.001), VAC (ρ = -0.7972, P < 0.001) and aortic diameter at the sinuses of Valsalva (ρ = 0.838, P < 0.001), sinotubular junction (ρ = 0.652, P = 0.002) and aortic arch (ρ = 0.701, P = 0.001).
DISCUSSION
The main findings of this study can be summarized as follows. (1) Women with a history of EO-PE, but not those who with a history of LO-PE, showed LV myocardial fibrosis. (2) LV myocardial fibrosis after PE was strongly associated with lower GA at onset of PE and higher UtA-PI. (3) LV cIBS findings correlated with myocardial contractility and cardiac performance indices (i.e. 2D strain and VAC), while aortic cIBS parameters correlated with arterial stiffness (i.e. cfPWV), aortic dimensions and VAC.
PE is characterized by persistent LV myocardial dysfunction as well as structural abnormalities and diastolic impairment 3, 4 . It is well established that a history of PE carries a two-fold risk of death from CV causes, which increases to an eight-fold risk in women with previous EO-PE 18 . The process of myocardial remodeling is not well understood. Myocyte damage following an insult, such as hypoxia-ischemia, toxicity or inflammation, leads to loss of function and eventually cell death by necrosis or apoptosis. Myocardial fibrosis is the natural replacement of dead myocytes in the heart. It has been demonstrated in several cardiopathies, and can be quantified accurately by endomyocardial biopsy or studied non-invasively with CMR. At present, contrast-enhanced CMR is the non-invasive gold-standard technique to evaluate 'late gadolinium enhancement' (LGE), a marker of tissue fibrosis and edema that has been widely validated against histology 19, 20 . Large studies have demonstrated that both the presence and extent of LV fibrosis are predictors, independent of LV ejection fraction, of ventricular arrhythmias and CV mortality in patients suffering from heart failure [21] [22] [23] [24] [25] . Using CMR, Masci et al. 26 recently investigated the prognostic value of myocardial fibrosis, demonstrating that both the presence and the burden of myocardial fibrosis influenced clinical outcome. Dealing with asymptomatic patients with non-ischemic cardiomyopathy and no history of heart failure, these authors hypothesized that baseline LGE evaluation is capable of predicting the transition from the asymptomatic to the symptomatic stage of heart failure 26 . However, in routine clinical practice, assessment of myocardial fibrosis using CMR is hampered by its high cost and limited availability. cIBS, in contrast, is widely available, and provides information on myocardial reflectivity to ultrasound that correlates directly with fibrosis at biopsy 9, 10 and with systodiastolic impairment 27, 28 . It necessitates specific training, since it is affected by image quality and signal noise, as well as insonation angulation issues. Inter-and intraobserver variability have been reported to be excellent 12, 13 . To the best of our knowledge, this is the first study to assess myocardial fibrosis in asymptomatic women with a history of PE. Our findings suggest that EO-PE is characterized by LV fibrosis in the short-medium term after delivery, and that this correlates with cardiac structural and functional abnormalities, as demonstrated previously 4 . These findings may suggest another possible explanation for the higher risk of CV events later in life in these women than in the general female population of the same age. Currently, fibrosis is considered as both a dynamic marker of CV disease severity and a determinant of future LV remodeling 26, 29, 30 . Although no therapies are able to reverse this process, the myocardial interstitium as a site of fibrosis is the focus of research efforts 31 . Arterial stiffness and impaired aortic elasticity have been demonstrated in women with a history of PE, particularly in those who experienced EO-PE 6,7,32-34 . Through its elasticity or stiffness, the aorta plays a key role in LV performance and remodeling affecting afterload and coronary perfusion in diastole 4, 6, [35] [36] [37] . Consequently, arterial stiffness is widely considered to be an independent predictor of CV morbidity 38, 39 . It is also able to predict hypertension in previously normotensive subjects 40 and provides an additional value in the CV risk profile [41] [42] [43] [44] [45] . We hypothesized that the inflammatory state and the oxidative stress during and following PE could contribute directly to arterial stiffening in these women, thereby damaging indirectly the aortic vasa vasorum 4, 6 . We evaluated for the first time aortic fibrosis by means of cIBS. We documented a non-statistically significant trend towards aortic fibrosis in women with a history of EO-PE. The presence of aortic fibrosis correlated with aortic diameters and aortic elastic properties. We can therefore hypothesize that vascular fibrosis triggered by oxidative stress and inflammation is one of the pathways of PE-induced CV damage. However, these findings should be interpreted cautiously due to the technical difficulties in measuring cIBS AO , which was obtained in fewer than half of the sample. This was due to the difficulty in visualizing adequately the tubular tract and to the thinness of the anterior aortic wall.
Limitations of the study include the small number of patients involved. Also, the lack of echocardiograms preconception and during pregnancy, with which to compare our findings, prevented us from establishing whether the observed fibrosis was a consequence of the PE or an alteration already present before pregnancy. Third, cIBS is still used purely as a research instrument rather than a clinical tool, since it is affected by poor image quality and signal noise. Moreover, existing data support its use only for IBS IVS and IBS PW , as other segments tend to suffer from greater variability of the signal related to angulation. We believe this to be the first report of cIBS AO , albeit without a validation study; the aim was to provide exploratory data and correlate it with previously studied parameters of aortic dimension and function. Finally, no data exist on the relationship between cIBS and CMR; however, both techniques have been validated against histology on endomyocardial biopsy 9, 10, 19, 20 . In conclusion, women with a history of PE, particularly those with previous EO-PE, show LV fibrosis, which is related to myocardial contractility and cardiac performance, and is associated independently with lower GA and higher UtA-PI at PE onset. Moreover, women with previous PE share a tendency towards aortic fibrosis, which is related to increased aortic diameters and impaired aortic elastic properties. Risk stratification in women with a history of PE therefore constitutes a crucial part of patient management, with implications for surveillance, treatment and outcome. Our findings suggest that detection and quantification of replacement fibrosis may represent useful markers for CV risk stratification of patients who have experienced PE, particularly EO-PE. Further studies are needed to test the usefulness of evaluating LV and aortic fibrosis in the prediction of CV outcome in these women. Figure S1 and Tables S1-S3 may be found in the online version of this article.
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